Management of early esophageal cancer.

Management of early esophageal cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Management of early esophageal cancer. Abstract Text:

J Theisen,M Feith,H J Stein,J R Siewert,J Theisen,M Feith,H J Stein,J R Siewert,

In early esophageal cancer, squamous cell cancer and early adenocarcinoma must be managed differently because they have different origins, pathogenesis. and clinical characteristics. The current treatment options vary widely, from extended resection with lymphadenectomy to endoscopic mucosectomy or ablation. None of these treatment options can be recommended universally. Instead, an individualized strategy should be based on the depth of tumor infiltration into the mucosa or submucosa, the presence or absence of lymph node metastases, the multicentricity of tumor growth, the length of the segment of intestinal metaplasia, and comorbidities of the patient. Endoscopic mucosectomy may be sufficient in a subset of patients who have m1 or m2 squamous cell carcinoma and in patients who have isolated foci of high-grade intraepithelial neoplasia or mucosal cancer. Surgical resection is the treatment of choice for carcinomas invading the submucosal and multicentric tumors. Limited resection with jejunal interposition provides an effective treatment option for patients who have early esophageal adenocarcinoma. The onset of lymph node involvement is later in patients who have early adenocarcinoma than in patients who have squamous cell cancer, probably because chronic injury and repair mechanisms obliterate the otherwise abundant lymph vessels.

Management of early esophageal cancer. Publishing Authors By Initials

J Theisen,M Feith,HJ Stein,JR Siewert,J Theisen,M Feith,HJ Stein,JR Siewert,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Management of early esophageal cancer. Journal Published:

PUBLICATION TYPE: Review

Journal: Advances in surgery

VOLUME: 41

Page Numbers: 229-39

Journal Abbreviation:

ISSN: 0065-3411

DAY: 1

MONTH: 11

YEAR: 2007

Management of early esophageal cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 45335

Management of early esophageal cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Management of early esophageal cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Management of early esophageal cancer.

AFFILIATION: Department of Surgery, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaningerstr.22, 81675 München, Germany. theisen@chir.med.tu-muenchen.de

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Adv Surg

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Management of early esophageal cancer Related Publications

• Detection of circulating tumor cells in blood using an optimized density gradient centrifugation.
• Fulminate intracardiac thrombosis associated with Budd-Chiari-syndrome and inferior vena cava thrombosis.
• Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival.
• Malignant degeneration of Barrett's esophagus: clinical point of view.
• Malignant progression in Barrett's esophagus: pathology and molecular biology.
• Management of early esophageal cancer.
• Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
• Risk analysis in esophageal surgery.
• Stent implantation as a treatment option in patients with thoracic anastomotic leaks after esophagectomy.
• Telomere length and hTERT expression in patients with colorectal carcinoma.
• [Ambulatory surgery at the surgical clinic and polyclinic of the Munich Technical University]
• [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus]
• [Combined therapy of inoperable esophageal cancer]
• [Counter-indicated, unnecessary and superfluous surgical methods]
• [Diagnostic procedure in postoperative complications]
• [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?]
• [Gastrointestinal hormones and lower esophageal sphincter]
• [Motility disorders as a pathogenetic principle: esophagus and cardia]
• [Motility disorders as a pathogenetic principle: introduction]
• [Possibilities of telecommunications in surgery]
• [Preoperative risk and postoperative follow-up in surgery of esophageal carcinoma]
• [Principles of radical surgery]
• [R1 resection in the surgery of upper gastrointestinal tumors : Relevance and therapeutic consequences.]
• [Reflux esophagitis from the surgical viewpoint]
• [Severe reflux esophagitis--conservative versus operative treatment. The surgical viewpoint]
• [Technical requirements and possibilities of teleconsultation in laparoscopic interventions]
• [The quality of life of patients with stomach and esophageal cancers]
• [Therapy of esophageal diverticula]
• [Trends in gastroenterologic intensive care medicine: suppurative cholangitis--surgery]
• [Value of clinical and experimental results for general practice in esophageal surgery]